Physician profile
Mark A Mahan
NPI 1477733426
$698,033.43
in general payments reported to CMS, 2019-2025
32 companies · $300K in 2025
The $300K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $22K · 2021: $42K · 2022: $80K · 2023: $29K · 2024: $183K · 2025: $300K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $361K · Consulting Fee: $80K · Travel and Lodging: $58K · Food and Beverage: $7,528 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $361,329.90 |
| Consulting Fee | $79,569.98 |
| Travel and Lodging | $57,723.24 |
| Food and Beverage | $7,528.40 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $399,473.65 | 2023-2025 | Arthrex |
| Joimax, INC. | $205,669.63 | 2019-2025 | |
| Axogen | $23,425.79 | 2019-2023 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Spineology INC. | $21,036.44 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Richard Wolf Medical Instruments Corp. | $8,445.37 | 2022 | |
| Riwospine, INC. | $7,854.45 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $6,750.00 | 2022 | |
| Spr Therapeutics, INC | $6,081.08 | 2020-2021 | |
| Cerapedics INC. | $5,588.82 | 2022 | |
| Synthes Gmbh | $3,529.20 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $3,100.00 | 2023 | Koselugo |
| Stryker Corporation | $2,137.35 | 2025 | Spinemap |
| Aesculap Implant Systems, LLC | $1,307.05 | 2022 | |
| Boston Scientific Corporation | $1,156.39 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $370.46 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $306.64 | 2022 | |
| Nevro Corp. | $215.04 | 2019-2022 | |
| Providence Medical Technology, INC. | $196.10 | 2024 | |
| Globus Medical, INC. | $171.56 | 2022-2025 | Senza |
| Alphatec Spine, INC | $154.93 | 2024 | |
| Checkpoint Surgical, INC | $145.89 | 2019 | |
| Saluda Medical Americas, INC. | $139.73 | 2023-2024 | Evoke Scs, Evoke |
| Nuvasive, INC. | $139.48 | 2022 | |
| Si-Bone, INC. | $113.46 | 2019 | |
| Piedmont Plus Innovation | $92.82 | 2024 | |
| Orthofix Medical, INC. | $89.63 | 2023 | Newbridge, M6-C |
| Medtronic USA, INC. | $82.17 | 2019 | |
| Coastal Medical Technologies LLC | $72.61 | 2024 | |
| Active Medical, LLC | $69.49 | 2024-2025 | |
| Camber Spine Technologies LLC | $54.50 | 2019 | |
| Avita Medical Americas, LLC | $46.54 | 2024 | |
| Pylant Medical | $17.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.